Navigation Links
Inexpensive Compound Could Treat Severe Diarrhea
Date:6/17/2008

Finding may be 'magic bullet' to help miilions of children in developing world, study says

TUESDAY, June 17 (HealthDay News) -- A new compound that may lead to an inexpensive, easy-to-take treatment for diarrhea has been discovered by researchers at the University of Texas Health Science Center at Houston.

This finding may prove especially important for developing countries, where diarrhea is a major cause of child deaths. Diarrhea kills an estimated 1.6 million to 2.5 million children a year, according to information published by the World Health Organization.

The new compound -- a pyridopyrimidine derivative -- targets E. coli and other enterotoxigenic strains of bacteria that cause acute secretory diarrhea. These bacteria produce toxins that stimulate the linings of the intestines, causing them to secrete excessive fluid, resulting in diarrhea.

In preclinical tests on animals infected with diarrhea-causing bacteria, the new compound was associated with a significant reduction in intestinal fluid secretion. The compound also reduced fluid build-up in laboratory tests on human cells. There was no indication of toxicity caused by the compound.

The research was published in the June 16 online edition of the journal Proceedings of the National Academy of Sciences.

"While this research looks extremely promising as a preventive or therapeutic intervention in Third World diarrheal disease and traveler's diarrhea, much work remains to be done to move into clinical trials and eventual therapeutic approval," study senior author Dr. Ferid Murad cautioned in a prepared statement.

A drug based on this compound may also prove effective in treating inflammatory bowel disease and some endocrine disorders, Murad said.

The discovery of this compound is "a promising lead," said Dr. Stanley G. Schultz, a cellular signaling expert at the University of Texas Medical School at Houston who was not involved in the study.

"An inexpensive drug that could block the intestinal secretory pathway, with minimal side effects, would be a 'magic bullet' that would not only save millions of lives in many parts of the developing world, but would also save the billions of dollars that are lost annually because of diarrhea throughout the world. It would truly be a treatment of diarrhea rather than a treatment of the consequences of diarrhea," Schultz said in a prepared statement.

Currently, there is no effective way to directly treat secretory diarrhea. Treatment is aimed at minimizing fluid loss through intravenous or oral rehydration.

More information

The American College of Gastroenterology has more about diarrheal diseases.



-- Robert Preidt



SOURCE: University of Texas Health Science Center at Houston, news release, June 16, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel
2. Study: Before a CT scan or angiogram, many people should take inexpensive drug to protect kidneys
3. Inexpensive Online Pain Education Program for Physicians as Effective as Live Presentations by National Experts
4. UCR chemists use green chemistry to produce amines, chemical compounds used widely in industry
5. Telik Announces Patents on Compounds Related to TELINTRA
6. New PA Economic Study: Bush Medicare Cuts Compound State Medicaid Crisis
7. Red Wine Compound Helps Heart, May Slow Aging
8. New Compound Slows HIV Replication
9. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
10. Patients, Doctors, Pharmacists Praise Bipartisan House Resolution on Compounded Hormones Containing Estriol
11. Grapefruit Compound Inhibits Hepatitis C Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to stabilize critical ... leave patients with dental emergencies at risk of losing a tooth or their smiles. ... , Common dental emergencies include:, , Avulsed or knocked-out ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ... Care Association™ (ALCA) to conduct a survey that takes a closer look at cases ... illustrates the prevalence and causes of TBI among the aging population, and identifies the ...
(Date:2/10/2016)... ... 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused ... full year ended December 31, 2015 on Monday, February 29, 2016 after the market ... community following the release at 4:30 PM ET. Investors interested in participating by phone ...
(Date:2/10/2016)... ... ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves with age, ... Guide to Brain Training" by award-winning author Phyllis Strupp explains how brain ... 16, 2016. A free review copy is available to the media at NetGalley ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX Health & ... PEEK-lined stainless steel (PLS) columns combine the strength of traditional stainless steel with ... of biological samples while operating at ultra-high pressures of 20,000 psi. The higher ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... SUNNYVALE, Calif. , Feb. 10, 2016 /PRNewswire/ ... Warren Kocmond , formerly Executive Vice President ... the position of President and Chief Operating Officer.  ... been expanded, and now include Global Commercial Operations ... and Customer Service.  Mr. Kocmond will continue to ...
(Date:2/10/2016)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), today announced ... full year ended December 31, 2015. ... year for Vanda with the continued growth of HETLIOZ ... HETLIOZ for Non-24," said Mihael H. Polymeropoulos, M.D., Vanda,s ... U.S. product portfolio builds on this success and underscores ...
(Date:2/10/2016)... LEXINGTON, Massachusetts , February 10, 2016 --> ... Japan .  --> Japan .  ... Japan .  With submission, Shire continues to ... --> With submission, Shire continues to ... With submission, Shire continues to strengthen ...
Breaking Medicine Technology: